Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2004
01/15/2004US20040009990 Especially piperidinylcarbonyl- and piperazinylcarbonyl-derivatives of indoles having oxalyl groups
01/15/2004US20040009988 Inhibiting hepatic production of apoprotein B-100 and microsomal triglyceride transfer protein to decrease VLDL and chylomicrons production
01/15/2004US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections.
01/15/2004US20040009976 Hypoglycemic imidazoline compounds
01/15/2004US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles
01/15/2004US20040009969 Diazacycloalkanes containing a 2,5-dioxo-1H-pyrrolyl- or 4-oxo-2-thioxoimidazolidinyl- groups; treating prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism and androgen-dependent acne.
01/15/2004US20040009968 Indazole compounds useful as protein kinase inhibitors
01/15/2004US20040009967 May contain further anticancer or immunosuppressive agents
01/15/2004US20040009966 Interleukin converting enzyme inhibitors
01/15/2004DE10228090A1 Ausgewählte Anthranylamidpyridinamide und deren Verwendung als Arzneimittel Selected Anthranylamidpyridinamide and their use as medicaments
01/15/2004CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
01/15/2004CA2492035A1 N-hydroxyamide derivatives possessing antibacterial activity
01/15/2004CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists
01/15/2004CA2491835A1 Mch1r antagonists
01/15/2004CA2491477A1 Indolin phenylsulfonamide derivatives
01/15/2004CA2491464A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
01/15/2004CA2490707A1 Method of using ryanodine antagonists in treating neural injury
01/15/2004CA2490463A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough
01/15/2004CA2490148A1 2, 5-substituted pyrimidine derivatives as ccr-3 receptor antagonists ix
01/15/2004CA2489251A1 Quinazoline derivatives
01/15/2004CA2489166A1 Substituted anthranilic amide derivatives and methods of use
01/14/2004EP1380584A1 Process for making 5-substituted pyrazoles using dithietanes
01/14/2004EP1380582A1 FSH mimetics for the treatment of infertility
01/14/2004EP1380579A1 Novel physiologically active substances
01/14/2004EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds
01/14/2004EP1379525A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
01/14/2004EP1379524A2 Chromane derivatives, process for their preparation and their use as antitumor agents
01/14/2004EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
01/14/2004EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
01/14/2004EP1379516A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
01/14/2004EP1379515A1 Lipid lowering biphenylcarboxamides
01/14/2004EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers
01/14/2004EP1379504A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
01/14/2004EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
01/14/2004EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
01/14/2004EP1379246A1 Nociceptin analogs
01/14/2004EP1379240A1 Compounds and methods
01/14/2004EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/14/2004EP1379238A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
01/14/2004EP1286965B1 Piperidine compounds and process for providing such
01/14/2004EP1189900B1 Heterocyclic aminopyrrolidine derivatives as melatonergic agents
01/14/2004CN1468233A Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
01/14/2004CN1468232A Heterocyclic sodium/proton exchange inhibitors and method
01/14/2004CN1468225A 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
01/14/2004CN1468220A New piperidine derivatives
01/14/2004CN1468217A Aliphatic nitrogenous five-membered ring compounds
01/14/2004CN1468216A Nitrogenous five-membered ring compounds
01/14/2004CN1468113A Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
01/14/2004CN1468112A The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
01/14/2004CN1134444C Epothilone analog and medicine combination
01/14/2004CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate
01/14/2004CN1134438C Bicyclic heteroaromatic compounds, method for prepearing the same and uses
01/14/2004CN1134433C Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
01/14/2004CN1134431C 2,4-diaminopyrimidine derivatives as dopamine D4 receptor antagonists
01/14/2004CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
01/14/2004CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists
01/13/2004US6677372 N-(3-benzofuranyl)urea-derivatives
01/13/2004US6677365 Antagonists of MCP-1 function and methods of use thereof
01/13/2004US6677357 Nerve growth factor; animal growth regulator; antitmor agent
01/13/2004US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders
01/13/2004US6677337 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
01/13/2004US6677333 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient
01/13/2004US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus
01/13/2004US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
01/13/2004US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
01/08/2004WO2004003102A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
01/08/2004WO2004002986A2 Novel benzimidazole derivatives
01/08/2004WO2004002977A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
01/08/2004WO2004002964A1 Diaminopyrimidinecarboxa mide derivative
01/08/2004WO2004002960A1 Substituted quinoline ccr5 receptor antagonists
01/08/2004WO2004002957A1 Novel tetrahydropyridine derivatives as renin inhibitors
01/08/2004WO2004002948A1 Amide compound and medicinal use thereof
01/08/2004WO2004002483A1 Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer’s disease
01/08/2004WO2004002470A1 Compounds useful for the inhibition of aldh
01/08/2004WO2003078625A3 An improved method for synthesising templated molecules
01/08/2004WO2003076429A3 Azepane derivatives and their use as atk1 inhibitors
01/08/2004WO2003042234A3 Non-peptide somatostatin receptor ligands
01/08/2004WO2002080164A9 Optical recording medium
01/08/2004US20040006233 Synthetic multimerizing agents
01/08/2004US20040006230 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
01/08/2004US20040006227 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
01/08/2004US20040006124 Administering compound that is a ryanodine receptor antagonist in pharmaceutically acceptable vehicle to inhibit or prevent nerve cell injury or death
01/08/2004US20040006123 Interleukin-4 gene expression inhibitors
01/08/2004US20040006114 Potentiators of glutamate receptors
01/08/2004US20040006107 For prophylaxis of asthma and other allergic diseases
01/08/2004US20040006105 Thrombin receptor antagonists
01/08/2004US20040006101 Quinolinone derivatives
01/08/2004US20040006094 For prophylaxis of ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event
01/08/2004US20040006089 For therapy of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome
01/08/2004US20040006082 For therapy and prophylaxis of diabetes, diabetic complications, diabetic retinopathy, obesity or asthma, hypoglycemic agent, an improving agent for impaired glucose tolerance, a potentiating agent for insulin sensitivity
01/08/2004US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
01/08/2004US20040006080 Chemical compounds
01/08/2004US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease
01/08/2004US20040006069 For therapy inflammatory and immune system disorders such as stroke, myocardial infarction, atherosclerosis, ischemic heart disease, ischemia-reperfusion injury
01/08/2004US20040006067 Substituted piperidines and methods of use
01/08/2004US20040006047 Heterocyclic amides, a process for their preparation, compositions comprising them and their use
01/08/2004US20040006007 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
01/08/2004US20040005986 Pyridazin-3-one derivatives, their use, and intermediates for their production
01/08/2004DE10226943A1 Phenylaminopyrimidine und ihre Verwendung Phenylaminopyrimidine and their use